Literature DB >> 27940298

Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Morgan K Penny1, Isabella Finco2, Gary D Hammer3.   

Abstract

The adrenal cortex is a dynamic tissue responsible for the synthesis of steroid hormones, including mineralocorticoids, glucocorticoids, and androgens in humans. Advances have been made in understanding the role of adrenocortical stem/progenitor cell populations in cortex homeostasis and self-renewal. Recently, large molecular profiling studies of adrenocortical carcinoma (ACC) have given insights into proteins and signaling pathways involved in normal tissue homeostasis that become dysregulated in cancer. These data provide an impetus to examine the cellular pathways implicated in adrenocortical disease and study connections, or lack thereof, between adrenal homeostasis and tumorigenesis, with a particular focus on stem and progenitor cell pathways. In this review, we discuss evidence for stem/progenitor cells in the adrenal cortex, proteins and signaling pathways that may regulate these cells, and the role these proteins play in pathologic and neoplastic conditions. In turn, we also examine common perturbations in adrenocortical tumors (ACT) and how these proteins and pathways may be involved in adrenal homeostasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenal cortex; Adrenal tumor; Adrenocortical adenoma; Adrenocortical carcinoma; Progenitor cells; Stem cells

Mesh:

Substances:

Year:  2016        PMID: 27940298      PMCID: PMC5508551          DOI: 10.1016/j.mce.2016.12.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  145 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  The role of fibroblast growth factor receptor 4 overexpression and gene amplification as prognostic markers in pediatric and adult adrenocortical tumors.

Authors:  Luciana Pinto Brito; Tamaya Castro Ribeiro; Madson Q Almeida; Alexander Augusto de Lima Jorge; Iberê Cauduro Soares; Ana Claudia Latronico; Berenice Bilharinho Mendonca; Maria Candida Barisson Villares Fragoso; Antonio Marcondes Lerario
Journal:  Endocr Relat Cancer       Date:  2012-05-03       Impact factor: 5.678

3.  Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.

Authors:  F L Sun; W L Dean; G Kelsey; N D Allen; W Reik
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

Authors:  Florence de Fraipont; Michelle El Atifi; Nadia Cherradi; Gwennaelle Le Moigne; Geneviève Defaye; Rémi Houlgatte; Jérôme Bertherat; Xavier Bertagna; Pierre-François Plouin; Eric Baudin; François Berger; Christine Gicquel; Olivier Chabre; Jean-Jacques Feige
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

Review 5.  Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.

Authors:  Edward P Carter; Abbie E Fearon; Richard P Grose
Journal:  Trends Cell Biol       Date:  2014-11-29       Impact factor: 20.808

6.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Authors:  Joanne H Heaton; Michelle A Wood; Alex C Kim; Lorena O Lima; Ferdous M Barlaskar; Madson Q Almeida; Maria C B V Fragoso; Rork Kuick; Antonio M Lerario; Derek P Simon; Ibere C Soares; Elisabeth Starnes; Dafydd G Thomas; Ana C Latronico; Thomas J Giordano; Gary D Hammer
Journal:  Am J Pathol       Date:  2012-07-15       Impact factor: 4.307

7.  Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.

Authors:  Delphine Vezzosi; Rossella Libé; Camille Baudry; Marthe Rizk-Rabin; Anelia Horvath; Isaac Levy; Fernande René-Corail; Bruno Ragazzon; Constantine A Stratakis; Grégoire Vandecasteele; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

8.  Transcriptional profiling enables molecular classification of adrenocortical tumours.

Authors:  Cecilia Laurell; David Velázquez-Fernández; Kristina Lindsten; Christofer Juhlin; Ulla Enberg; Janos Geli; Anders Höög; Magnus Kjellman; Joakim Lundeberg; Bertil Hamberger; Catharina Larsson; Peter Nilsson; Martin Bäckdahl
Journal:  Eur J Endocrinol       Date:  2009-05-01       Impact factor: 6.664

9.  Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.

Authors:  Cristina L Ronchi; Guido Di Dalmazi; Simon Faillot; Silviu Sbiera; Guillaume Assié; Isabel Weigand; Davide Calebiro; Thomas Schwarzmayr; Silke Appenzeller; Beatrice Rubin; Jens Waldmann; Carla Scaroni; Detlef K Bartsch; Franco Mantero; Massimo Mannelli; Darko Kastelan; Iacopo Chiodini; Jerome Bertherat; Martin Reincke; Tim M Strom; Martin Fassnacht; Felix Beuschlein
Journal:  J Clin Endocrinol Metab       Date:  2016-07-07       Impact factor: 5.958

10.  Localization of Sonic hedgehog secreting and receiving cells in the developing and adult rat adrenal cortex.

Authors:  Leonardo Guasti; Alex Paul; Ed Laufer; Peter King
Journal:  Mol Cell Endocrinol       Date:  2010-11-20       Impact factor: 4.102

View more
  3 in total

1.  Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.

Authors:  Emilia Modolo Pinto; Carlos Rodriguez-Galindo; Stanley B Pounds; Lei Wang; Michael R Clay; Geoffrey Neale; Elizabeth A R Garfinkle; Catherine G Lam; Carolyn Fein Levy; Alberto S Pappo; Gerard P Zambetti; Raul C Ribeiro
Journal:  J Clin Oncol       Date:  2017-10-23       Impact factor: 44.544

2.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

3.  MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation.

Authors:  Tatiana V Novoselova; Mashal Hussain; Peter J King; Leonardo Guasti; Louise A Metherell; Marika Charalambous; Adrian J L Clark; Li F Chan
Journal:  FASEB J       Date:  2018-06-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.